IL-35 can influence the transcription and expression of T cell immune response-related differentially expressed genes in tumor tissues (31), but the immunosuppressive activity of this cytokine is primarily attributable to its inhibition of CD4+ and CD8+T cells and of anti-tumor immune responses (Figure 1) (39). This evidence concerns the gene CD4 and neoplasm.